- Report
- August 2025
- 187 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- April 2025
- 147 Pages
Global
From €3485EUR$3,999USD£3,026GBP
- Report
- January 2026
- 179 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- January 2026
- 340 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- January 2026
- 287 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- January 2026
- 451 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- January 2026
- 192 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- January 2026
- 196 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- January 2026
- 286 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- October 2025
- 250 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- September 2025
- 250 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- September 2025
- 250 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- September 2025
- 250 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- April 2025
- 175 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- April 2025
- 200 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- April 2025
- 200 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- April 2025
- 200 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- April 2025
- 200 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- April 2025
- 200 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1743EUR$2,000USD£1,513GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more